Neuroscience
There is a Brain Bank accessible to the international community, a Multiple Sclerosis (MS) center at the VUmc, and Alzheimer’s centres at both the VUmc and the AMC. The MS and Alzheimer’s centres are built on a multidisciplinary approach in order to optimise patient care, scientific research and education around these diseases. They have a strong international reputation and long track records of multiple collaborations with industry on drug development and fundamental research, and they exploit state-of-the art imaging technologies.
The VU also harbours a Centre for Neurogenomics and Cognitive Research, which has developed an integrated neurosciences programme, based on genomics and pharmaco-genomics and proteomics.
Neurological research programmes focus on the design of novel early diagnostic tools and biomarkers to follow the efficacy of new drugs. Developing such new clinical outcome measurements is crucial to drug development for neurological disorders.
Main therapy targets
- Alzheimer's disease
- Epilepsy
- Multiple sclerosis
- Stress and depression
Main therapies and tools
- Biomarkers
- Electrophysiology
- Imaging (MRI, MEG) (Microscopy)
- Netherlands Brain Bank
- Patient cohorts
